المؤلفون: Pooja Ghatalia (800258), Chad H. Smith (6237707), Arthur Winer (2469907), Jiangtao Gou (2834915), Lesli A. Kiedrowski (6237710), Michael Slifker (676659), Patricia D. Saltzberg (6237713), Nicole Bubes (6237716), Fern M. Anari (6237719), Vineela Kasireddy (6237722), Asya Varshavsky (270534), Yang Liu (4829), Eric A. Ross (3147168), Wafik S. El-Deiry (10765014)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, liquid biopsy, precision oncology, molecular target, tumor heterogeneity, drug resistance, tumor burden, cfDNA

Relation: https://figshare.com/articles/dataset/Table_1_Clinical_Utilization_Pattern_of_Liquid_Biopsies_LB_to_Detect_Actionable_Driver_Mutations_Guide_Treatment_Decisions_and_Monitor_Disease_Burden_During_Treatment_of_33_Metastatic_Colorectal_Cancer_mCRC_Patients_pts_at_a_Fox_Chase_Cance/14555700

الاتاحة: https://doi.org/10.3389/fonc.2018.00652.s001